Summary:
This podcast features a panel discussion from the 2024 PODD Conference with biopharma leaders about biomaterial approaches to develop implants that can deliver molecules and optimize for dose frequency. Specifically:
- Defining biocompatible materials and biomaterials
- Differences between small and larger molecules
- Benefits and challenges of implants
To learn more about the PODD conference, please visit Drug-Delivery.org.
Moderators
Cameron Lee, PhD
Associate Director
Novartis Institutes for BioMedical Research
Panelists
C Eric Elmquist, PhD
COO of R&D
Pendant Biosciences
Jaymin Shah, PhD
Senior Research Fellow and Head of Biopharmaceutics
Pfizer
Eileen Sadeghi, PhD
Senior Scientist II
AbbVie
Milin Shah, PhD
Director, Biotech Ecosystem Development
Thermo Fisher Scientific
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.